Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma

Journal of Clinical Virology

Volumn 53, Issue 1, 2012, Pages 65-71

  Plavina, Tatiana ^a   Berman, Melissa ^a   Njenga, Moses ^a   Crossman, Mary ^a   Lerner, Michaela ^a   Gorelik, Leonid ^a   Simon, Kenneth ^a   Schlain, Brian ^a   Subramanyam, Meena ^a  

^a 14 Cambridge Center ^*  (United States)

Author keywords

Anti JC virus (JCV) antibody; Enzyme linked immunosorbent assay, ELISA; Progressive multifocal leukoencephalopathy, PML; Validated assay; Virus like particles, VLP

Indexed keywords

JC VIRUS ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ACCURACY; ANTIBODY SCREENING; ARTICLE; BK VIRUS; CLINICAL LABORATORY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JC VIRUS; JC VIRUS INFECTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PROTEIN STABILITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 83355166273     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.10.003     Document Type: Article

References (16)

1. Major E. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010, 61:35-47.
2. Berger J.R. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf 2010, 33:969-983.
3. Gorelik L., Lerner M., Bixler S., Crossman M., Schlain B., Simon K., et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 2010, 68:295-303.
4. Guidance for Industry on Bioanalytical Method Validation, prepared by the Biopharmaceutics Coordinating Committee in the Center for Drug Evaluation and Research (CDER) in cooperation with the Center for Veterinary Medicine (CVM) at the Food and Drug Administration (USA) May 2001.
5. DeSilva B., Smith W., Weiner R., Kelley M., Smolec J., Lee B., et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res 2003, 1885-1900.
6. Egli A., Infanti L., Dumoulin A., Buser A., Samaridis J., Stebler C., et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009, 199:837-846.
7. Krymskaya L., Sharma M.C., Martinez J., Haq W., Huang E.C., Limaye A.P., et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005, 79:11170-11178.
8. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Validation of analytical procedures: text and methodology Q2(R1) 2005, 5. ICH, Geneva, Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.
9. Antonsson A., Green A.C., Mallitt K.A., O'Rourke P.K., Pandeya N., Pawlita M., et al. Prevalence and stability of antibodies to 37 human papillomavirus types - a population-based longitudinal study. Virology 2010, 407:26-32.
10. Ryschkewitsch C.F., Jensen P.N., Monaco M.C., Major E.O. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 2010, 68:384-391.
11. Grabowski M.K., Viscidi R.P., Margolick J.B., Jacobson L.P., Shah K.V. Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients. J Med Virol 2009, 81:1140-1150.
12. Stolt A., Sasnauskas K., Koskela P., Lehtinen M., Dillner J. Seroepidemiology of human polyoma viruses. J Gen Virol 2003, 84:1499-1504.
13. Carter J.J., Madeleine M.M., Wipf G.C., Garcea R.L., Pipkin P.A., Minor P.D., et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003, 95:1522-1530.
14. Matos A., Duque V., Beato S., da Silva J.P., Major E., Meliço-Silvestre A. Characterization of JC human polyomavirus infection in a Portuguese population. J Med Virol 2010, 82:494-504.
15. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5:e1000363.
16. Tysabri [prescribing information] 2011, Biogen Idec Inc., Cambridge, MA.